Improving Outcomes for Stage I Bladder Cancer
Paul Crispen, MD, defines recurrence rates in stage I bladder cancer. He characterizes established methods to decrease disease recurrence and helps us to recognize barriers to implementing methods that would improve outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.